Neither compound, nor any other peptide on this list, substitutes for consistent resistance training, adequate protein intake, and sufficient recovery, which remain the primary drivers of muscle growth regardless of which peptide a person considers
Key Takeaways BPC-157 has no FDA-approved dose and no validated human dosing protocol
In an experimental model of induced fatigue bone damage, administration of CGRP or CGRP(837) increased reparative bone formation [74]
However, a localized injection is often preferred in research to achieve a higher concentration at the target site
Users commonly report 2.5-5mg per day via subcutaneous injection, often once daily or split
Compound Review is an independent research publication